Stock DUA DUALITY S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Duality S.A.

Equities

DUA

PLDLITY00010

End-of-day quote Warsaw S.E.
Other stock markets
 23:00:00 27/06/2024 BST 		5-day change 1st Jan Change
1.52 PLN +2.01% Intraday chart for Duality S.A. -0.98% +2.70%
05-15 Duality S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-20 Duality S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Duality S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024
Duality S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
BioNTech to Present Clinical Data Updates on Cancer Vaccine Candidates
Tod's CEO says he has no plans to sell 'family business'
LATE BRIEFING - Unternehmen und Märkte
BioNTech, Duality Biologics Obtain FDA Fast Track Designation for Ovarian Cancer Therapy Candidate
BioNTech's Cancer Therapy Candidate Obtains Fast-track Designation from US FDA
BioNTech, Duality Biologics Initiate Phase 3 Trial of Breast Cancer Drug
BioNTech Begins Late-stage Study for Metastatic Breast Cancer Therapy Candidate
Biontech treibt mit Partner Entwicklung von Krebsmittel voran
BioNTech challenges AstraZeneca with breast cancer precision drug trial
LATE BRIEFING - Unternehmen und Märkte -2-
BioNTech, Duality Biologics Get US FDA Breakthrough Therapy Designation for Uterine Cancer Drug Candidate
Duality S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Duality S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
HBM Holdings, Beigene Sign License Deal for Antibody-Drug Conjugate Program; HBM Shares Soar 20%
Duality S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
LATE BRIEFING - Unternehmen und Märkte
BioNTech, DualityBio Sign Strategic Partnership to Develop ADC Therapeutics to Treat Solid Tumors
BioNTech Partners With DualityBio to Develop Cancer Treatments
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DUA Stock
  4. News Duality S.A.
  5. Other languages